Concepedia

John F. Worzalla

JF

Statistics

Publications

22

Citations

946

H-Index

17

Active since

1968

Affiliations

Eli Lilly (United States)(Current)

John F. Worzalla is an author at Eli Lilly (United States) specializing in pharmacology, cancer pharmacology, and medicine.

Publications per year

1968–1999

22

Publications

22

Studies on the Mechanism of Phosphatidylinositol 3-Kinase Inhibition by Wortmannin and Related Analogs

Bryan H. Norman, Chuan Shih, John E. Toth et al. · Journal of Medicinal Chemistry · 1996 · 118 citations

, , +15

Role of thymidylate synthase in the antitumor activity of the multitargeted antifolate, LY231514.

Richard M. Schultz, Vinod F. Patel, John F. Worzalla et al. · PubMed · 1999 · 111 citations

, , +11

Cell cycle modulation by a multitargeted antifolate, LY231514, increases the cytotoxicity and antitumor activity of gemcitabine in HT29 colon carcinoma.

John L. Tonkinson, John F. Worzalla, C H Teng et al. · PubMed · 1999 · 97 citations

, , +16

Augmentation of the therapeutic activity of lometrexol -(6-R)5,10-dideazatetrahydrofolate- by oral folic acid.

Teresa Alati, John F. Worzalla, C Shih et al. · PubMed · 1996 · 67 citations

, , +9

Metabolism of hexamethylmelamine-ring-14C in rats and man.

John F. Worzalla, Bernard D. Kaiman, Bruce M. Johnson et al. · PubMed · 1974 · 62 citations

, , +10

1–5 of 22